These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6714394)

  • 1. [Physical properties and availability of chloramphenicol palmitate in powdered mixtures containing microcrystalline cellulose].
    Cameroni R; Coppi G; Forni F; Bernabei MT
    Farmaco Prat; 1984 Mar; 39(3):76-86. PubMed ID: 6714394
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of grinding on the transformations of polymorphs of chloramphenicol palmitate.
    Kaneniwa N; Otsuka M
    Chem Pharm Bull (Tokyo); 1985 Apr; 33(4):1660-8. PubMed ID: 4042241
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pseudomorphism of chloramphenicol stearate and palmitate in relationship availability].
    Cameroni R; Coppi G; Forni F; Gamberini G; Ferioli V
    Farmaco Prat; 1983 Apr; 38(4):173-82. PubMed ID: 6861978
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study on tablets. XX. Further knowledge of powdered and microcrystalline cellulose].
    Heliová M; Chalabala M; Malý J
    Cesk Farm; 1972 Jul; 21(6):261-6. PubMed ID: 5068872
    [No Abstract]   [Full Text] [Related]  

  • 5. Relative bioavailability of intravenous chloramphenicol succinate and oral chloramphenicol palmitate in infants and children.
    Kauffman RE; Thirumoorthi MC; Buckley JA; Aravind MK; Dajani AS
    J Pediatr; 1981 Dec; 99(6):963-7. PubMed ID: 7310593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Crystallinity and equivalence of chloramphenicol palmitate].
    Bernabei MT; Forni F; Coppi G; Iannuccelli V; Cameroni R
    Farmaco Prat; 1983 Nov; 38(11):391-402. PubMed ID: 6653747
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of grinding on physical and chemical properties of crystalline medicinals with microcrystalline cellulose. I. Some physical properties of crystalline medicinals in ground mixtures.
    Nakai Y; Fukuoka E; Nakajima S; Yamamoto K
    Chem Pharm Bull (Tokyo); 1977 Dec; 25(12):3340-6. PubMed ID: 608225
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in material properties accompanying the national formulary (NF) identity test for microcrystalline cellulose.
    Brittain HG; Lewen G; Newman AW; Fiorelli K; Bogdanowich S
    Pharm Res; 1993 Jan; 10(1):61-7. PubMed ID: 8430061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetic evaluation of 2 oral forms of chloramphenicol in children with typhoid].
    Bravo ME; Horwitz I; Sánchez A; Arancibia A
    Rev Chil Pediatr; 1986; 57(2):121-5. PubMed ID: 3550926
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioavailability and pharmacokinetics of chloramphenicol palmitate in malnourished children.
    Mahta S; Nain CK; Kalsi HK; Mathur VS
    Indian J Med Res; 1981 Aug; 74():244-50. PubMed ID: 6796509
    [No Abstract]   [Full Text] [Related]  

  • 11. [Physicochemical properties and intestinal absorption of a ground mixture of chloramphenicol palmitate with microcrystalline cellulose (author's transl].
    Yamamoto K; Matsuda S; Nakano M; Arita T; Nakai Y
    Yakugaku Zasshi; 1977 Apr; 97(4):367-72. PubMed ID: 559740
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of grinding on the physical and chemical properties of crystalline medicinals with microcrystalline cellulose. IV. Comparison of the IR spectra of medicinals in the solid state and in solution.
    Nakai Y; Nakajima S; Yamamoto K; Terada K; Konno T
    Chem Pharm Bull (Tokyo); 1980 Feb; 28(2):652-6. PubMed ID: 7389026
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bioavailability of chloramphenicol palmitate suspension].
    Morasso MI; Hirmas E; Firmani E; Pezoa R; Cid E
    Pharm Acta Helv; 1980; 55(10):270-3. PubMed ID: 7454734
    [No Abstract]   [Full Text] [Related]  

  • 14. [Polarography of chloramphenicol palmitate].
    Pflegel P; Shoukrallah I
    Pharmazie; 1974 May; 29(5):316-20. PubMed ID: 4849413
    [No Abstract]   [Full Text] [Related]  

  • 15. A differential assay for chloramphenicol and chloramphenicol succinate based upon a sensitive assay for the parent drug [proceedings].
    Guest RT; Byron PR; Gescher A
    J Pharm Pharmacol; 1979 Dec; 31 Suppl():22P. PubMed ID: 42695
    [No Abstract]   [Full Text] [Related]  

  • 16. Adamantylmethyl analogues of chloramphenicol.
    Mullen GB; Georgiev VS
    J Pharm Sci; 1988 Jul; 77(7):643-4. PubMed ID: 3171956
    [No Abstract]   [Full Text] [Related]  

  • 17. Rearrangement of chloramphenicol-3-monosuccinate.
    Brent DA; Chandrasurin P; Ragouzeos A; Hurlbert BS; Burke JT
    J Pharm Sci; 1980 Aug; 69(8):906-8. PubMed ID: 6249906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, plasma protein binding and dosage of chloramphenicol in cattle and horses.
    Pilloud M
    Res Vet Sci; 1973 Sep; 15(2):231-8. PubMed ID: 4803578
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chloramphenicol at a veal-calf stock farm].
    Jorna IP; Postema HJ
    Tijdschr Diergeneeskd; 1986 May; 111(10):471-5. PubMed ID: 3715829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural, electronic, thermodynamical and charge transfer properties of Chloramphenicol Palmitate using vibrational spectroscopy and DFT calculations.
    Mishra R; Srivastava A; Sharma A; Tandon P; Baraldi C; Gamberini MC
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Jan; 101():335-42. PubMed ID: 23123240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.